Taisho Pharmaceutical Holdings Co., Ltd. reported consolidated earnings results for the fiscal year ended March 31, 2013. For the period, the company reported net sales were ¥285,168 million, operating income was ¥35,337 million, ordinary income was ¥44,173 million and net income was ¥26,320 million or ¥325.26 per share and ¥325.22 per diluted share compared to net sales of ¥271,230 million, operating income of ¥38,412 million, ordinary income ¥46,201 million and net income of ¥24,357 million or ¥296.20 per share last year. Return on equity was 4.8% compared to 4.6% last year. Income before income taxes and minority interests was ¥2,571 million against ¥3,865 million last year. Income before minority interests was ¥27,577 million against ¥25,251 million last year. Net cash provided by operating activities was ¥41,292 million compared to ¥23,732 million last year. Payments for purchases of tangible fixed assets were ¥11,285 million against ¥7,426 million last year. Payments for purchases of intangible fixed assets were ¥1,396 million compared to ¥3,813 million last year. Net cash provided by operating activities represents a year-on-year increase of ¥17.6 billion mainly attributable to income before income taxes and minority interests of ¥43.2 billion. For the first half of fiscal 2013, on consolidated basis, the company expects net sales of ¥144,500 million, operating income of ¥20,500 million, ordinary income of ¥24,500 million and net income of ¥15000 million or ¥184.97 per share. For the full year ending March 31, 2014, on consolidated basis, the company expects net sales of ¥293,000 million, operating income of ¥39,500 million, ordinary income of ¥47,500 million and net income of ¥30,000 million or ¥369.94 per share. For the year ended March 31, 2013, the company announced dividend of ¥60.00 per share against ¥50.00 per share last year. Total dividend is ¥120.00 per share against ¥50.00 per share last year. The dividend is payable on June 28, 2013. For the second quarter of fiscal year 2013, the company expects dividend of ¥50.00 per share. For the year, the company expects dividend of ¥60.00 per share. Total dividend for the year ending March 31, 2014 is expected to be ¥110.00 per share. The company's dividend policy has been set to roughly correspond to the consolidated operating results for each business term. The goal has been a dividend payout ratio of 30% of net income excluding extraordinary gains and losses. The company intends to maintain its annual dividend at the minimum of ¥100 per share even if it is apparent that the dividend payout ratio will exceed 30%, unless there are exceptional circumstances.

Taisho Pharmaceutical Holdings Co., Ltd. announced that they will report fiscal year 2013 results on May 10, 2013

Taisho Pharmaceutical Holdings Co., Ltd. Presents at Daiwa Investment Conference Tokyo 2013, Mar-04-2013 . Venue: The Prince Park Tower Tokyo, Tokyo, Japan.